Barthel index for stroke trials: development, properties, and application.

Quinn Terence J, Langhorne Peter, Stott David J

Stroke · 2011 · PMID 21372310 · 인용 696

PubMed ↗DOI ↗

BACKGROUND AND

PURPOSE: Robust measures of functional outcome are required to determine treatment effects in stroke trials. Of the various measures available, the Barthel index (BI) is one of the more prevalent. We aimed to describe validity, reliability, and responsiveness (clinimetric properties) of the BI in stroke trials.

METHODS: Narrative review of published articles describing clinimetric properties or use of the BI as a stroke trial end point.

RESULTS: Definitive statements on properties of BI are limited by heterogeneity in methodology of assessment and in the content of "BI" scales. Accepting these caveats, evidence suggests that BI is a valid measure of activities of daily living; sensitivity to change is limited at extremes of disability (floor and ceiling effects), and reliability of standard BI assessment is acceptable. However, these data may not be applicable to contemporary multicenter stroke trials.

CONCLUSIONS: Substantial literature describing BI clinimetrics in stroke is available; however, questions remain regarding certain properties. The "BI" label is used for a number of instruments and we urge greater consistency in methods, content, and scoring. A 10-item scale, scoring 0 to 100 with 5-point increments, has been used in several multicenter stroke trials and it seems reasonable that this should become the uniform stroke trial BI.

🏛️ 거인의 어깨이 분야를 만든 논문들

일상생활 수행 능력을 평가하는 표준 지표를 제시하여 재활 의학의 객관적 평가 체계를 확립했습니다.

↳ 2011년 재해석본으로 연결

원저에는 초록이 없습니다 — 여기 쓰인 초록·이야기는 2011년 해설 논문에 기댑니다.

이야기를 쓰는 중…